Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort
Takaki Oka,Yuki Matsuzawa,Momoka Tsuneyoshi,Yoshitaka Nakamura,Ken Aoshima,Hiroshi Tsugawa,Michael Weiner,Paul Aisen,Ronald Petersen,Clifford R. Jack,William Jagust,John Q. Trojanowki,Arthur W. Toga,Laurel Beckett,Robert C. Green,Andrew J. Saykin,John Morris,Leslie M. Shaw,Enchi Liu,Tom Montine,Ronald G. Thomas,Michael Donohue,Sarah Walter,Devon Gessert,Tamie Sather,Gus Jiminez,Danielle Harvey,Michael Donohue,Matthew Bernstein,Nick Fox,Paul Thompson,Norbert Schuff,Charles DeCArli,Bret Borowski,Jeff Gunter,Matt Senjem,Prashanthi Vemuri,David Jones,Kejal Kantarci,Chad Ward,Robert A. Koeppe,Norm Foster,Eric M. Reiman,Kewei Chen,Chet Mathis,Susan Landau,Nigel J. Cairns,Erin Householder,Lisa Taylor Reinwald,Virginia Lee,Magdalena Korecka,Michal Figurski,Karen Crawford,Scott Neu,Tatiana M. Foroud,Steven Potkin,Li Shen,Faber Kelley,Sungeun Kim,Kwangsik Nho,Zaven Kachaturian,Richard Frank,Peter J. Snyder,Susan Molchan,Jeffrey Kaye,Joseph Quinn,Betty Lind,Raina Carter,Sara Dolen,Lon S. Schneider,Sonia Pawluczyk,Mauricio Beccera,Liberty Teodoro,Bryan M. Spann,James Brewer,Helen Vanderswag,Adam Fleisher,Judith L. Heidebrink,Joanne L. Lord,Ronald Petersen,Sara S. Mason,Colleen S. Albers,David Knopman,Kris Johnson,Rachelle S. Doody,Javier Villanueva Meyer,Munir Chowdhury,Susan Rountree,Mimi Dang,Yaakov Stern,Lawrence S. Honig,Karen L. Bell,Beau Ances,John C. Morris,Maria Carroll,Sue Leon,Erin Householder,Mark A. Mintun,Stacy Schneider,Angela Oliver,Daniel Marson,Randall Griffith,David Clark,David Geldmacher,John Brockington,Erik Roberson,Hillel Grossman,Effie Mitsis,Leyla de Toledo-Morrell,Raj C. Shah,Ranjan Duara,Daniel Varon,Maria T. Greig,Peggy Roberts,Marilyn Albert,Chiadi Onyike,Daniel D'Agostino,Stephanie Kielb,James E. Galvin,Dana M. Pogorelec,Brittany Cerbone,Christina A. Michel,Henry Rusinek,Mony J. de Leon,Lidia Glodzik,Susan De Santi,P. Murali Doraiswamy,Jeffrey R. Petrella,Terence Z. Wong,Steven E. Arnold,Jason H. Karlawish,David Wolk,Charles D. Smith,Greg Jicha,Peter Hardy,Partha Sinha,Elizabeth Oates,Gary Conrad,Oscar L. Lopez,MaryAnn Oakley,Donna M. Simpson,Anton P. Porsteinsson,Bonnie S. Goldstein,Kim Martin,Kelly M. Makino,M. Saleem Ismail,Connie Brand,Ruth A. Mulnard,Gaby Thai,Catherine Mc Adams Ortiz,Kyle Womack,Dana Mathews,Mary Quiceno,Ramon Diaz Arrastia,Richard King,Myron Weiner,Kristen Martin Cook,Michael DeVous,Allan I. Levey,James J. Lah,Janet S. Cellar,Jeffrey M. Burns,Heather S. Anderson,Russell H. Swerdlow,Liana Apostolova,Kathleen Tingus,Ellen Woo,Daniel H. S. Silverman,Po H. Lu,George Bartzokis,Neill R. Graff Radford,Francine Parfitt,Tracy Kendall,Heather Johnson,Martin R. Farlow,Ann Marie Hake,Brandy R. Matthews,Scott Herring,Cynthia Hunt,Christopher H. van Dyck,Richard E. Carson,Martha G. MacAvoy,Howard Chertkow,Howard Bergman,Chris Hosein,Sandra Black,Bojana Stefanovic,Curtis Caldwell,Ging Yuek Robin Hsiung,Howard Feldman,Benita Mudge,Michele Assaly,Andrew Kertesz,John Rogers,Dick Trost,Charles Bernick,Donna Munic,Diana Kerwin,Marek Marsel Mesulam,Kristine Lipowski,Chuang Kuo Wu,Nancy Johnson,Carl Sadowsky,Walter Martinez,Teresa Villena,Raymond Scott Turner,Kathleen Johnson,Brigid Reynolds,Reisa A. Sperling,Keith A. Johnson,Gad Marshall,Meghan Frey,Jerome Yesavage,Joy L. Taylor,Barton Lane,Allyson Rosen,Jared Tinklenberg,Marwan N. Sabbagh,Christine M. Belden,Sandra A. Jacobson,Sherye A. Sirrel,Neil Kowall,Ronald Killiany,Andrew E. Budson,Alexander Norbash,Patricia Lynn Johnson,Thomas O. Obisesan,Saba Wolday,Joanne Allard,Alan Lerner,Paula Ogrocki,Leon Hudson,Evan Fletcher,Owen Carmichael,John Olichney,Charles DeCarli,Smita Kittur,Michael Borrie,T. Y. Lee,Rob Bartha,Sterling Johnson,Sanjay Asthana,Cynthia M. Carlsson,Steven G. Potkin,Adrian Preda,Dana Nguyen,Pierre Tariot,Adam Fleisher,Stephanie Reeder,Vernice Bates,Horacio Capote,Michelle Rainka,Douglas W. Scharre,Maria Kataki,Anahita Adeli,Earl A. Zimmerman,Dzintra Celmins,Alice D. Brown,Godfrey D. Pearlson,Karen Blank,Karen Anderson,Robert B. Santulli,Tamar J. Kitzmiller,Eben S. Schwartz,Kaycee M. Sink,Jeff D. Williamson,Pradeep Garg,Franklin Watkins,Brian R. Ott,Henry Querfurth,Geoffrey Tremont,Stephen Salloway,Paul Malloy,Stephen Correia,Howard J. Rosen,Bruce L. Miller,Jacobo Mintzer,Kenneth Spicer,David Bachman,Elizabether Finger,Stephen Pasternak,Irina Rachinsky,John Rogers,Andrew Kertesz,Dick Drost,Nunzio Pomara,Raymundo Hernando,Antero Sarrael,Susan K. Schultz,Laura L. Boles Ponto,Hyungsub Shim,Karen Elizabeth Smith,Norman Relkin,Gloria Chaing,Lisa Raudin,Amanda Smith,Kristin Fargher,Balebail Ashok Raj,the Alzheimer's Disease Metabolomics Consortium
DOI: https://doi.org/10.1038/s41598-024-56837-1
IF: 4.6
2024-04-02
Scientific Reports
Abstract:Alzheimer's disease (AD) is a neurodegenerative disease that commonly causes dementia. Identifying biomarkers for the early detection of AD is an emerging need, as brain dysfunction begins two decades before the onset of clinical symptoms. To this end, we reanalyzed untargeted metabolomic mass spectrometry data from 905 patients enrolled in the AD Neuroimaging Initiative (ADNI) cohort using MS-DIAL, with 1,304,633 spectra of 39,108 unique biomolecules. Metabolic profiles of 93 hydrophilic metabolites were determined. Additionally, we integrated targeted lipidomic data (4873 samples from 1524 patients) to explore candidate biomarkers for predicting progressive mild cognitive impairment (pMCI) in patients diagnosed with AD within two years using the baseline metabolome. Patients with lower ergothioneine levels had a 12% higher rate of AD progression with the significance of P = 0.012 (Wald test). Furthermore, an increase in ganglioside (GM3) and decrease in plasmalogen lipids, many of which are associated with apolipoprotein E polymorphism, were confirmed in AD patients, and the higher levels of lysophosphatidylcholine (18:1) and GM3 d18:1/20:0 showed 19% and 17% higher rates of AD progression, respectively (Wald test: P = 3.9 × 10 –8 and 4.3 × 10 –7 ). Palmitoleamide, oleamide, diacylglycerols, and ether lipids were also identified as significantly altered metabolites at baseline in patients with pMCI. The integrated analysis of metabolites and genomics data showed that combining information on metabolites and genotypes enhances the predictive performance of AD progression, suggesting that metabolomics is essential to complement genomic data. In conclusion, the reanalysis of multiomics data provides new insights to detect early development of AD pathology and to partially understand metabolic changes in age-related onset of AD.
multidisciplinary sciences